Frédérique Nowak

669 total citations
22 papers, 356 citations indexed

About

Frédérique Nowak is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Frédérique Nowak has authored 22 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Frédérique Nowak's work include Colorectal Cancer Treatments and Studies (9 papers), Cancer Genomics and Diagnostics (7 papers) and Lung Cancer Treatments and Mutations (7 papers). Frédérique Nowak is often cited by papers focused on Colorectal Cancer Treatments and Studies (9 papers), Cancer Genomics and Diagnostics (7 papers) and Lung Cancer Treatments and Mutations (7 papers). Frédérique Nowak collaborates with scholars based in France, Switzerland and Denmark. Frédérique Nowak's co-authors include Jean‐Charles Soria, Fabien Calvo, Joan Aurich‐Costa, Anne Vannier, Dorra Chérif, Patrice Viens, Isabelle Rouquette, Julien Mazières, Gérard Zalcman and Alain Jacquemin‐Sablon and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Biochemical Pharmacology.

In The Last Decade

Frédérique Nowak

20 papers receiving 348 citations

Peers

Frédérique Nowak

PRM

ONCOL

CR

MB

PFM

Thomas Ferguson Australia

Brenda Ernst United States

Ali Saber Netherlands

Stephanie A. Hamilton United States

Md Abu Shufean United States

Erica Quaquarini Italy

Joana Ribeiro Portugal

Claudia Lefeuvre France

Karen Briscoe Australia

Mia M. Gaudet United States

Thomas Ferguson Australia

Frédérique Nowak

133 ×0.7

PRM

227 ×1.3

ONCOL

171 ×1.3

CR

101 ×0.8

MB

30 ×0.5

PFM

Citations per year, relative to Frédérique Nowak Frédérique Nowak (= 1×) peers Thomas Ferguson

Countries citing papers authored by Frédérique Nowak

Since Specialization

Citations

This map shows the geographic impact of Frédérique Nowak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédérique Nowak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédérique Nowak more than expected).

Fields of papers citing papers by Frédérique Nowak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédérique Nowak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédérique Nowak. The network helps show where Frédérique Nowak may publish in the future.

Co-authorship network of co-authors of Frédérique Nowak

This figure shows the co-authorship network connecting the top 25 collaborators of Frédérique Nowak. A scholar is included among the top collaborators of Frédérique Nowak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédérique Nowak. Frédérique Nowak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Edsjö, Anders, Birgit Geoerger, Frédérique Nowak, et al.. (2023). Precision cancer medicine: Concepts, current practice, and future developments. Journal of Internal Medicine. 294(4). 455–481. 31 indexed citations

2.

Marion, Mathieu, et al.. (2023). Vers un consentement plus éclairé. médecine/sciences. 39(8-9). 650–657. 1 indexed citations

3.

Buzyn, Agnès, Jean‐Yves Blay, Natalie Hoog-Labouret, et al.. (2016). Equal access to innovative therapies and precision cancer care. Nature Reviews Clinical Oncology. 13(6). 385–393. 25 indexed citations

4.

Blay, Jean‐Yves, Claire Cropet, Julien Mazières, et al.. (2016). Biomarker-driven access to vemurafenib in BRAF-positive cancers: Second study of the French National AcSé Program.. Journal of Clinical Oncology. 34(15_suppl). TPS11620–TPS11620. 2 indexed citations

5.

Piton, Nicolas, et al.. (2015). Real-Life Distribution of KRAS and NRAS Mutations in Metastatic Colorectal Carcinoma from French Routine Genotyping. Cancer Epidemiology Biomarkers & Prevention. 24(9). 1416–1418. 15 indexed citations

6.

Moro‐Sibilot, Denis, Laura Faivre, Gérard Zalcman, et al.. (2015). Crizotinib in patients with advanced ROS1-rearranged non-small cell lung cancer (NSCLC). Preliminary results of the ACSé phase II trial.. Journal of Clinical Oncology. 33(15_suppl). 8065–8065. 38 indexed citations

7.

Vassal, Gilles, Marie‐Cécile Le Deley, Marta Jimenez, et al.. (2014). Biomarker-driven access to crizotinib in ALK-, MET-, or ROS1-positive malignancies in adults and children: Feasibility of the French National Acsé Program.. Journal of Clinical Oncology. 32(15_suppl). TPS2647–TPS2647.

8.

Nowak, Frédérique. (2013). Modèle de compte rendu de génétique moléculaire pour la recherche de mutations somatiques dans les tumeurs solides. Annales de Pathologie. 33(1). 3–8.

9.

Emile, Jean‐François, Julie Tisserand, Loïc Bergougnoux, et al.. (2013). Improvement of the quality of BRAF testing in melanomas with nationwide external quality assessment, for the BRAF EQA group. BMC Cancer. 13(1). 472–472. 9 indexed citations

10.

Nowak, Frédérique, Fabien Calvo, & Jean‐Charles Soria. (2013). Europe Does It Better: Molecular Testing across a National Health Care System—The French Example. American Society of Clinical Oncology Educational Book. 33. 332–337. 13 indexed citations

11.

Nowak, Frédérique, Fabien Calvo, & Jean‐Charles Soria. (2013). Europe Does It Better: Molecular Testing across a National Health Care System—The French Example. American Society of Clinical Oncology Educational Book. 332–337. 5 indexed citations

12.

Pujol, Pascal, Dominique Stoppa‐Lyonnet, Thierry Frébourg, et al.. (2013). Referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: A nationwide study based on 240,134 consultations and 134,652 genetic tests.. Journal of Clinical Oncology. 31(15_suppl). 1528–1528. 1 indexed citations

13.

Nowak, Frédérique, Jean‐Charles Soria, & Fabien Calvo. (2012). Tumour molecular profiling for deciding therapy—the French initiative. Nature Reviews Clinical Oncology. 9(8). 479–486. 57 indexed citations

14.

André, Fabrice, Frédérique Nowak, Mónica Arnedos, et al.. (2012). Biomarker Discovery, Development, and Implementation in France: A Report from the French National Cancer Institute and Cooperative Groups. Clinical Cancer Research. 18(6). 1555–1560. 27 indexed citations

15.

Landais, Paul, Valérie Méresse, Arnaud Olivier, et al.. (2009). Evaluation and Validation of Diagnostic Tests for Guiding Therapeutic Decisions. Therapies. 64(3). 195–201. 8 indexed citations

16.

Landais, Paul, Valérie Méresse, Arnaud Olivier, et al.. (2009). Évaluation et validation des tests diagnostiques dans le cadre du ciblage thérapeutique. Therapies. 64(3). 187–194. 5 indexed citations

17.

Aurich‐Costa, Joan, et al.. (2001). IPM-FISH, a new M-FISH approach using IRS-PCR painting probes: Application to the analysis of seven human prostate cell lines. Genes Chromosomes and Cancer. 30(2). 143–143. 5 indexed citations

18.

Aurich‐Costa, Joan, Anne Vannier, Eric Grégoire, Frédérique Nowak, & Dorra Chérif. (2001). IPM-FISH, a new M-FISH approach using IRS-PCR painting probes: Application to the analysis of seven human prostate cell lines. Genes Chromosomes and Cancer. 30(2). 143–160. 23 indexed citations

19.

Nowak, Frédérique, Alain Jacquemin‐Sablon, & Josiane Pierre. (1997). Expression of the Activated p185erbB2Tyrosine Kinase in Human Epithelial Cells Leads to MAP Kinase Activation but Does Not Confer Oncogenicity. Experimental Cell Research. 231(2). 251–259. 5 indexed citations

20.

Nowak, Frédérique, Alain Jacquemin‐Sablon, & Josiane Pierre. (1997). Epidermal growth factor receptor signaling cascade as target for tyrphostin (RG 50864) in epithelial cells. Biochemical Pharmacology. 53(3). 287–298. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact